Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 289,458 | 306,099 | 303,428 | 272,598 | 276,935 |
| Cost of Goods | 106,441 | 102,751 | 98,829 | 96,011 | 91,744 |
| Gross Profit | 183,017 | 203,348 | 204,599 | 176,587 | 185,191 |
| Operating Expenses | 143,471 | 158,277 | 138,430 | 138,594 | 130,073 |
| Operating Income | 39,987 | 45,822 | 66,998 | 38,004 | 55,862 |
| Other Income | 184 | -4,162 | -5,914 | -4,617 | -6,304 |
| Pre-tax Income | 40,171 | 41,660 | 61,084 | 33,387 | 49,558 |
| Income Tax | 6,571 | 1,072 | 12,025 | 5,922 | -1,435 |
| Net Income Continuous | 33,600 | 40,588 | 49,059 | 27,465 | 50,993 |
| Net Income | $33,600 | $40,588 | $49,059 | $27,465 | $50,993 |
| EPS Basic Total Ops | 0.21 | 0.27 | 0.31 | 0.17 | 0.32 |
| EPS Basic Continuous Ops | 0.21 | 0.26 | 0.31 | 0.17 | 0.32 |
| EPS Diluted Total Ops | 0.21 | 0.26 | 0.31 | 0.17 | 0.31 |
| EPS Diluted Continuous Ops | 0.21 | 0.25 | 0.31 | 0.17 | 0.31 |
| EPS Diluted Before Non-Recurring Items | 0.37 | 0.49 | 0.44 | 0.33 | 0.35 |
| EBITDA(a) | $68,124 | $73,879 | $94,309 | $65,807 | $84,402 |